Effects of Drugs on Responses to Brain and Emotional Processes

Brief Summary

To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits

Intervention / Treatment

  • Drug: MDMA
  • Drug: Placebo Oral Tablet

Condition or Disease

  • Autism Spectrum Disorder
  • Healthy

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 21 Years to 40 Years   (Adult)
Enrollment: 24 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Aug 08, 2019
Primary Completion: Apr 12, 2021
Completion Date: Apr 12, 2021
Study First Posted: Aug 12, 2019
Results First Posted: Aug 30, 2020
Last Updated: Jun 09, 2021

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 21
Maximum Age: 40

More Details

NCT Number: NCT04053036
Acronym: MAT
Other IDs: IRB19-0174
Study URL: https://ClinicalTrials.gov/show/NCT04053036
Last updated: Jun 16, 2022